New drug tested in patients with liver problems
NCT ID NCT07165002
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study looks at how the drug LY3537031 is processed by the body in people with mild, moderate, or severe liver problems compared to healthy volunteers. About 32 adults will receive a single injection under the skin. The goal is to measure drug levels in the blood and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research Units Hungary
RECRUITINGKistarcsa, H-243, Hungary
Contact Phone: •••-•••-••••
Contact
-
New Zealand Clinical Research Auckland
RECRUITINGAuckland, 1010, New Zealand
Contact Phone: •••-•••-••••
Contact
-
Summit Clinical Research, s.r.o. - Bratislava
RECRUITINGBratislava, 831 01, Slovakia
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.